CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types

BACKGROUND: Cancer is a major threat to human health worldwide. Although recent innovations and advances in early detection and effective therapies such as targeted drugs and immune checkpoint inhibitors have saved more lives of cancer patients and improved their quality of life, our knowledge about...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Aimin, Zhou, Ye, Gong, Wenliang, Pan, Xin, Gan, Xinxin, Wu, Zhenjie, Liu, Bing, Qu, Le, Wang, Linhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989596/
https://www.ncbi.nlm.nih.gov/pubmed/35401923
http://dx.doi.org/10.1155/2022/5910575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989596/
https://www.ncbi.nlm.nih.gov/pubmed/35401923
http://dx.doi.org/10.1155/2022/5910575

Ejemplares similares